VitaDAO primarily funds translational R&D projects in longevity science. We are particulary interested in potentially revolutionary contributions to science. Find out about our funding process, project criteria, or submit a project for review below.
The $VITA governance token is a central component of the VitaDAO ecosystem. The token grants its holders rights to participate in decision-making within the DAO. Find out about out tokenomics and safely purchase the $VITA token below.
VitaDAO IP-NFT Transfer Ceremony with Molecule & Evandro Fang
March 22, 2022
Discovery of novel mitophagy activators for Alzheimer’s disease
Mitophagy - the mechanism to recycle mitochondria - becomes dysregulated with age and is thought to be a driver of Alzheimer’s and other age-related diseases. The Fang lab aims to use a combination of artificial intelligence and a wet-lab validation platform to identify new mitophagy-activating drug candidates.
Rubedo is building a platform for longevity medicines using “smart drugs” (prodrugs) that have the capacity to selectively be activated in target cells predicted to be pathogenic and the cause of age-related diseases.
Korolchuck lab proposes a drug discovery programme with the aim of identifying novel bioactive autophagy inducers. Activation of autophagy is considered a promising therapeutic approach to combat ageing and age-related diseases.
Turn Bio develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. They are reprogramming the epigenome – a network of chemical compounds and proteins controlling cell functions to restore capabilities that are lost with age.